Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2016 Jul;20(7):1470-7.
doi: 10.1007/s10461-015-1182-z.

Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women

Lisa M Kuhns  1   2 , Sari L Reisner  3   4 , Matthew J Mimiaga  3   4   5 , Travis Gayles  6   7 , Michael Shelendich  7 , Robert Garofalo  6   7
Affiliations
Multicenter Study

Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women

Lisa M Kuhns et al. AIDS Behav. 2016 Jul.

Abstract

Transgender women are at high risk of HIV infection, with younger transgender women (YTW) particularly vulnerable. Pre-Exposure Prophylaxis (PrEP) has shown efficacy in reducing HIV acquisition, but little is known about PrEP indication or initiation among YTW. Baseline data from 180 YTW age 18-29 years enrolled in Project LifeSkills, an on-going HIV prevention intervention for YTW, were analyzed to examine factors associated with PrEP indication. The sample (mean age = 23.4, SD = 3.2) was comprised largely of women of color (69 %) and of low socioeconomic status (71 % unemployed). Overall, 62 % met criteria for PrEP indication, but only 5 % reported ever taking PrEP. Factors associated with increased odds of PrEP indication were: PrEP interest (aOR 3.24; 95 % CI 1.44, 7.33), number of recent anal sex partners (aOR 1.23; 95 % CI 1.04, 1.46), and lower collective self-esteem scores (aOR 0.67; 95 % CI 0.47, 0.94). Despite high levels of PrEP indication, there remain low levels of PrEP awareness and uptake among YTW.

Trial registration: ClinicalTrials.gov NCT01575938.

Keywords: HIV; PrEP; Transgender; Young adults.

PubMed Disclaimer

References

    1. Herbst JH, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav. 2008;12(1):1–17. - PubMed
    1. Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–222. - PubMed
    1. Schulden JD, Song B, Barrosb A, Mares-DelGrasso A, Martind CW, Ramireze R, et al. Rapid HIV testing in transgender communities by community-based organizations in three cities. Public Health Rep. 2008;123:101–114. - PMC - PubMed
    1. Garofalo R, Deleon J, Osmer E, Doll M, Harper G. Overlooked, misunderstood and at-risk: exploring the lives and HIV risk of ethnic minority male-to-female transgender youth. J Adolesc Health. 2006;38:230–236. - PubMed
    1. Garofalo R, Osmer E, Sullivan C, Doll M, Harper G. Environmental, psychosocial, and individual correlates of HIV risk in ethnic minority male-to-female transgender youth. J HIV/AIDS Prev Child Youth. 2006;7(2):89–104.

Publication types

Substances

Associated data